O

ORIC Pharmaceuticals

Clinical-stage oncology company targeting resistance

Vice President of Biostatistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeSan Diego, CA, USA$320k - $350k /yr

About the Job

Requirements

  • A PhD or master's degree in Biostatistics, Statistics, or a related field.
  • At least 15 years of relevant experience in biotech or pharmaceutical research and development.
  • At least 7 years leading Biostatistics teams, including management of statisticians, programmers, and/or data management groups.
  • Demonstrated success shaping statistical strategy for pivotal trials and regulatory submissions.
  • Ability to influence senior stakeholders, navigate ambiguity, and drive alignment across cross-functional teams.
  • Deep understanding of global regulatory guidelines, data requirements, clinical operations interfaces, and inspection readiness.
  • Experience managing departmental budgets, vendor relationships, and technical infrastructure.
  • Ability to lead hands-on in a small-company environment.

Responsibilities

  • Lead the overall biostatistics strategy across clinical development programs, from early development through registration and post-marketing activities.
  • Provide statistical leadership for the design and execution of Phase 3 clinical trials, including adaptive designs and modeling approaches, endpoint selection, and sample size determination.
  • Oversee development of statistical analysis plans and contribute to clinical study reports and regulatory submission documents.
  • Lead data interpretation and support decision-making at key program milestones, including interim analyses and final data readouts.
  • Serve as the biostatistics lead in interactions with external data monitoring committees and global health authorities.
  • Oversee CROs, data vendors, and technology platforms to ensure high-quality deliverables, timely execution, and compliance with regulatory and industry standards.
  • Champion modern data management and statistical computing practices, ensuring infrastructure supports scale, audit readiness, and efficiency.
  • Stay current with emerging statistical methodologies, regulatory trends, and industry best practices.
  • Lead and mentor a high-performing biostatistics team, including internal staff and external vendors and CRO partners.

Desired Qualifications

  • Late-stage development experience, particularly in Oncology.
  • Experience contributing to late-stage development and regulatory submissions; NDA experience is strongly preferred.

About the Company

ORIC Pharmaceuticals

Clinical-stage oncology company targeting resistance

ORIC Pharmaceuticals is a clinical-stage cancer company focused on overcoming how cancers resist treatment. Its therapies aim to restore patients’ response to existing treatments by targeting resistance mechanisms. Lead programs include rinzimetostat (ORIC-944), an allosteric inhibitor of the PRC2 complex designed for prostate cancer, and enozertinib (ORIC-114), a brain-penetrant inhibitor that targets EGFR exon 20 and HER2 exon 20 mutations in non-small cell lung cancer. Early work continues on other resistance mechanisms across solid tumors. Unlike some competitors, ORIC concentrates specifically on breaking or bypassing resistance to current therapies, based on research from Memorial Sloan Kettering Cancer Center and brought to Nasdaq-listed status in 2020. Its goal is to improve how well existing cancer treatments work for patients by keeping cancer from outsmarting them.

Company size
51-200
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at ORIC Pharmaceuticals

See more jobs